Fabrinet Management

Management criteria checks 3/4

Fabrinet's CEO is Seamus Grady, appointed in Sep 2017, has a tenure of 7.25 years. total yearly compensation is $11.08M, comprised of 11.3% salary and 88.7% bonuses, including company stock and options. directly owns 0.026% of the company’s shares, worth $2.12M. The average tenure of the management team and the board of directors is 7.3 years and 13.3 years respectively.

Key information

Seamus Grady

Chief executive officer

US$11.1m

Total compensation

CEO salary percentage11.3%
CEO tenure7.3yrs
CEO ownership0.03%
Management average tenure7.3yrs
Board average tenure13.3yrs

Recent management updates

Recent updates

Getting In Cheap On Fabrinet (NYSE:FN) Might Be Difficult

Dec 03
Getting In Cheap On Fabrinet (NYSE:FN) Might Be Difficult

Is Now The Time To Look At Buying Fabrinet (NYSE:FN)?

Nov 19
Is Now The Time To Look At Buying Fabrinet (NYSE:FN)?

Does Fabrinet (NYSE:FN) Deserve A Spot On Your Watchlist?

Nov 06
Does Fabrinet (NYSE:FN) Deserve A Spot On Your Watchlist?

Are Investors Undervaluing Fabrinet (NYSE:FN) By 33%?

Oct 23
Are Investors Undervaluing Fabrinet (NYSE:FN) By 33%?

Fabrinet (NYSE:FN) Hasn't Managed To Accelerate Its Returns

Sep 26
Fabrinet (NYSE:FN) Hasn't Managed To Accelerate Its Returns

Fabrinet: Attractive Growth But Richly Priced

Sep 23

When Should You Buy Fabrinet (NYSE:FN)?

Aug 20
When Should You Buy Fabrinet (NYSE:FN)?

Fabrinet's (NYSE:FN) P/E Is On The Mark

Aug 07
Fabrinet's (NYSE:FN) P/E Is On The Mark

Fabrinet: Great Company But Prospects Already Priced In

Jul 25

Does Fabrinet (NYSE:FN) Have A Healthy Balance Sheet?

Jul 24
Does Fabrinet (NYSE:FN) Have A Healthy Balance Sheet?

If EPS Growth Is Important To You, Fabrinet (NYSE:FN) Presents An Opportunity

Jun 25
If EPS Growth Is Important To You, Fabrinet (NYSE:FN) Presents An Opportunity

Returns On Capital Are Showing Encouraging Signs At Fabrinet (NYSE:FN)

May 24
Returns On Capital Are Showing Encouraging Signs At Fabrinet (NYSE:FN)

Fabrinet: An AI Play In The Making

May 16

At US$173, Is It Time To Put Fabrinet (NYSE:FN) On Your Watch List?

May 01
At US$173, Is It Time To Put Fabrinet (NYSE:FN) On Your Watch List?

These 4 Measures Indicate That Fabrinet (NYSE:FN) Is Using Debt Safely

Apr 19
These 4 Measures Indicate That Fabrinet (NYSE:FN) Is Using Debt Safely

What You Can Learn From Fabrinet's (NYSE:FN) P/E

Apr 07
What You Can Learn From Fabrinet's (NYSE:FN) P/E

Is Now The Time To Put Fabrinet (NYSE:FN) On Your Watchlist?

Mar 13
Is Now The Time To Put Fabrinet (NYSE:FN) On Your Watchlist?

Fabrinet: Some Encouraging Narratives, But Best Not To Chase

Mar 04

Is Fabrinet (NYSE:FN) Worth US$216 Based On Its Intrinsic Value?

Mar 01
Is Fabrinet (NYSE:FN) Worth US$216 Based On Its Intrinsic Value?

Is Fabrinet (NYSE:FN) Potentially Undervalued?

Jan 25
Is Fabrinet (NYSE:FN) Potentially Undervalued?

Is Fabrinet (NYSE:FN) Using Too Much Debt?

Jan 13
Is Fabrinet (NYSE:FN) Using Too Much Debt?

Some Confidence Is Lacking In Fabrinet's (NYSE:FN) P/E

Jan 01
Some Confidence Is Lacking In Fabrinet's (NYSE:FN) P/E

Fabrinet: A Key Enabler Of The AI Revolution

Dec 23

Fabrinet: Datacenter AI Push Offsetting Telecom Weakness

Nov 21

Fabrinet's Datacom Business: A Beacon Of Growth

Oct 11

Fabrinet: Growth Story At A Fair Price

Aug 15

Buy Fabrinet On Discounted Valuation

May 26

Fabrinet Q2 2023 Earnings Preview

Feb 05

CEO Compensation Analysis

How has Seamus Grady's remuneration changed compared to Fabrinet's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 27 2024n/an/a

US$308m

Jun 28 2024US$11mUS$1m

US$296m

Mar 29 2024n/an/a

US$276m

Dec 29 2023n/an/a

US$254m

Sep 29 2023n/an/a

US$248m

Jun 30 2023US$11mUS$1m

US$248m

Mar 31 2023n/an/a

US$243m

Dec 30 2022n/an/a

US$235m

Sep 30 2022n/an/a

US$220m

Jun 24 2022US$10mUS$1m

US$200m

Mar 25 2022n/an/a

US$187m

Dec 24 2021n/an/a

US$173m

Sep 24 2021n/an/a

US$160m

Jun 25 2021US$8mUS$860k

US$148m

Mar 26 2021n/an/a

US$134m

Dec 25 2020n/an/a

US$125m

Sep 25 2020n/an/a

US$121m

Jun 26 2020US$8mUS$860k

US$113m

Mar 27 2020n/an/a

US$118m

Dec 27 2019n/an/a

US$119m

Sep 27 2019n/an/a

US$119m

Jun 28 2019US$6mUS$775k

US$121m

Mar 29 2019n/an/a

US$111m

Dec 28 2018n/an/a

US$103m

Sep 28 2018n/an/a

US$91m

Jun 29 2018US$5mUS$543k

US$84m

Compensation vs Market: Seamus's total compensation ($USD11.08M) is above average for companies of similar size in the US market ($USD8.00M).

Compensation vs Earnings: Seamus's compensation has been consistent with company performance over the past year.


CEO

Seamus Grady (57 yo)

7.3yrs

Tenure

US$11,082,191

Compensation

Mr. Seamus Grady has been Chief Executive Officer and Director at Fabrinet since September 22, 2017. Mr. Grady served as Executive Vice President and Chief Operating Officer, Mechanical Systems Division, a...


Leadership Team

NamePositionTenureCompensationOwnership
David Mitchell
Founder & Chairman24.9yrsUS$494.85k0.087%
$ 7.0m
Seamus Grady
CEO & Director7.3yrsUS$11.08m0.026%
$ 2.1m
Harpal Gill
President & COO15.8yrsUS$8.93m0.051%
$ 4.2m
Csaba Sverha
Executive VP & CFO4.8yrsUS$4.12m0%
$ 0
Edward Archer
Executive Vice President of Sales & Marketing5.9yrsUS$3.34mno data
Garo Toomajanian
Vice President of Investor Relationsno datano datano data
Colin Campbell
VP & General Counsel8.3yrsno datano data

7.3yrs

Average Tenure

61yo

Average Age

Experienced Management: FN's management team is seasoned and experienced (7.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
David Mitchell
Founder & Chairman24.9yrsUS$494.85k0.087%
$ 7.0m
Seamus Grady
CEO & Director7.3yrsUS$11.08m0.026%
$ 2.1m
Forbes I. Alexander
Independent Directorless than a yearUS$112.94kno data
Frank Levinson
Independent Director23.9yrsUS$328.35k0.012%
$ 986.4k
Homa Bahrami
Independent Director12.3yrsUS$319.85k0.054%
$ 4.4m
Thomas Kelly
Independent Director14.2yrsUS$337.85k0.053%
$ 4.3m
Rollance Olson
Lead Independent Director20.9yrsUS$345.85k0.065%
$ 5.2m
Darlene Knight
Independent Director2.9yrsUS$307.35k0.0088%
$ 709.3k

13.3yrs

Average Tenure

70yo

Average Age

Experienced Board: FN's board of directors are seasoned and experienced ( 13.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 07:40
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/27
Annual Earnings2024/06/28

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fabrinet is covered by 20 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
George WangBarclays
Jerome RamelBNP Paribas Exane